A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2002-04-01
The objective of this study is to evaluate the safety and efficacy of a one time dose of an
intravenous marketed drug being evaluated for a new indication as compared to a marketed drug
already approved for the prevention of surgical site infection following colorectal surgery.
A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2002-04-01
The objective of this study is to evaluate the safety and efficacy of a one time dose of an
intravenous marketed drug being evaluated for a new indication as compared to a marketed drug
already approved for the prevention of surgical site infection following colorectal surgery.
Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs
Completed
Santa Clara Valley Health & Hospital System
N/A
2003-09-01
This study is undertaken to find out whether prophylactic antibiotics can decrease the
infection rate in third and fourth degree perineal tear repairs done in the immediate
postpartum period.
Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs
Completed
Stanford University
N/A
2003-09-01
This study is undertaken to find out whether prophylactic antibiotics can decrease the
infection rate in third and fourth degree perineal tear repairs done in the immediate
postpartum period.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
